Find clinical trials for COVID-19 in Washington, DC
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
COVID-19 trials near Washington, DC, USA:
that suggests the potential for clinical benefit of COVID-19 patients.Treat Infection of Multiple Gene Mutation COVID-19...
Early Phase 1
North Bethesda, Maryland, United States
vaccine (SARS-CoV-2 rS) adjuvanted with Matrix-M™ in previously mRNA COVID-19 vaccinated adult participants ≥18 years of age and ba-...
Phase 2, Phase 3
Baltimore, Maryland, United States and 29 other locations
for infectious pneumonia acquired in the community (CAP), including COVID-19.Secondary objectives:- To determine the effect of repa...
Phase 3
Washington, District of Columbia, United States and 108 other locations
This study looks at the safety and effectiveness of AZD7442 in treating COVID-19 in people who have been hospitalized with the infe...
Phase 3
Washington, District of Columbia, United States and 123 other locations
COVID-19 is a systemic inflammatory disease involving many organs including the lungs, vascular system liver and myocardium that le-...
Baltimore, Maryland, United States
A study to investigate the prevention of COVID-19 with VYD222 in adults with immune compromise and in participants aged 12 years or...
Phase 3
Silver Spring, Maryland, United States and 17 other locations
A randomized, double-blind, placebo-controlled Phase 2/3 Study of LAU-7b against confirmed COVID-19 Disease in hospitalized patient...
Phase 2, Phase 3
Washington, District of Columbia, United States and 28 other locations
stratified, pivotal efficacy and safety study of the EmitBio RD-X19 treatment device in Individuals 40 Years of age and older with Mild COVID...
Rockville, Maryland, United States and 47 other locations
Performance of the LumiraDx SARS-CoV-2 Ag assay will be assessed by comparison to a reference method.
Millersville, Maryland, United States and 6 other locations
a completed primary series and bivalent booster of mRNA based COVID-19 vaccine and have =<2500 U/mL SARS-CoV-2 S antibody concentra...
Phase 2
Baltimore, Maryland, United States and 5 other locations
Clinical trials
Research sites
Resources
Legal